MedTrace Logo

Assessment of Visual Function in Ophthalmic Disorders Using Virtual Visual Field Analysis

NCT04110015 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2021-08-30

No results posted yet for this study

Summary

1. To evaluate the accuracy of virtual visual field (VVF) headsets equipped the standard visual field software in its ability to assess visual function in various retinal, glaucoma and neuro-ophthalmic disorders by comparing retinal fundus and optic nerve images, optical coherence tomography and neuroimages to the VVF produced.
2. To test the null hypothesis that VVF testing compares favorably to the gold standard, Humphrey visual field (HVF) by comparing testing time, mean sensitivity, markers of reliability including false positives and negatives and fixation losses and global indices such as mean deviation and pattern standard deviation.

Conditions

  • Visual Pathway Disorder
  • Glaucoma
  • Retinal Disease

Interventions

DEVICE

virtual visual field

Patients with identified conditions will be invited to do a virtual visual field test with virtual reality headsets.

Sponsors & Collaborators

  • New York City Health and Hospitals Corporation

    lead OTHER

Principal Investigators

  • JOYCE MBEKEANI · Albert Einstein College of Medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-10-01
Primary Completion
2020-10-30
Completion
2021-08-23

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04110015 on ClinicalTrials.gov